Animal Models of Affective Behaviors and Drug Addiction

  • Eva Drews
  • Astrid Becker
  • Andras Bilkei-Gorzo
  • Andreas Zimmer


Psychiatric disorders have a strong heritability, and like most common disorders many gene variants, each with a small effect yize , contribute to the genetic risk. One of the challenges in complex genetics is to determine how different alleles interact with each other and with the environment in the context of disease etiology. Here we discuss mouse models that resemble aspects of syndromes of human psychiatric disorders, with particular emphasis on depression and drug addiction. These disorders rank among the top 10 causes of disability and morbidity worldwide and often occur together, thus resulting in a greater severity of health-related consequences. Mice have become the premier research organism, due to their excellent genetics. We have a large and ever-increasing number of mouse strains with defined genetic backgrounds, and the possibilities of precise genetic manipulations seem almost unlimited. Furthermore, environmental factors that are thought to influence disease outcome can be controlled, thus enabling researchers to study interactions between genes and the environment.


Conditioned Place Preference Drug Addiction Progressive Ratio Tail Suspension Test Chronic Mild Stress 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Chronic mild stress


Cannabinoid receptor 1


Conditioned place preference


Diagnostic and Statistical Manual of Mental Disorders


Deoxyribonucleic acid


First filial generation


Forced swim test




Olfactory bulbectomy


Progressive ratio


Quantitative trait loci


Recombinant inbred


Simple sequence repeats


Selective serotonin reuptake inhibitors


Short tandem repeats


Tail suspension test


Ultrasonic vocalisation


Variable number tandem repeats


  1. Abuin A, Hansen GM, Zambrowicz B (2007) Gene trap mutagenesis. Handb Exp Pharmacol:129–147.Google Scholar
  2. Arguello PA, Gogos JA (2006) Modeling madness in mice: one piece at a time. Neuron 52:179–196.PubMedCrossRefGoogle Scholar
  3. Aronoff R, Petersen CC (2006) Controlled and localized genetic manipulation in the brain. J Cell Mol Med 10:333–352.PubMedCrossRefGoogle Scholar
  4. Association AP (1994) DSM IV – Diagnostic and statistical manual of psychiatric disorders, 4th Edition. American Psychiatric Association.Washington, DC:Google Scholar
  5. Belknap JK, Hitzemann R, Crabbe JC, Phillips TJ, Buck KJ, Williams RW (2001) QTL analysis and genomewide mutagenesis in mice: complementary genetic approaches to the dissection of complex traits. Behav Genet 31:5–15.PubMedCrossRefGoogle Scholar
  6. Bell IR, Hardin EE, Baldwin CM, Schwartz GE (1995) Increased limbic system symptomatology and sensitizability of young adults with chemical and noise sensitivities. Environ Res 70:84–97.PubMedCrossRefGoogle Scholar
  7. Bennett B, Downing C, Parker C, Johnson TE (2006) Mouse genetic models in alcohol research. Trends Genet 22:367–374.PubMedCrossRefGoogle Scholar
  8. Borsini F, Meli A (1988) Is the forced swimming test a suitable model for revealing antidepressant activity? Psychopharmacology (Berl) 94:147–160.CrossRefGoogle Scholar
  9. Branchi I, Santucci D, Vitale A, Alleva E (1998) Ultrasonic vocalizations by infant laboratory mice: a preliminary spectrographic characterization under different conditions. Dev Psychobiol 33:249–256.PubMedCrossRefGoogle Scholar
  10. Brault V, Pereira P, Duchon A, Herault Y (2006) Modeling chromosomes in mouse to explore the function of genes, genomic disorders, and chromosomal organization. PLoS Genet 2:e86.PubMedCrossRefGoogle Scholar
  11. Caldarone BJ, George TP, Zachariou V, Picciotto MR (2000) Gender differences in learned helplessness behavior are influenced by genetic background. Pharmacol Biochem Behav 66:811–817.PubMedCrossRefGoogle Scholar
  12. Carboni E, Vacca C (2003) Conditioned place preference. A simple method for investigating reinforcing properties in laboratory animals. Methods Mol Med 79:481–498.Google Scholar
  13. Cryan JF, Mombereau C (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatr 9:326–357.CrossRefGoogle Scholar
  14. Dalvi A, Lucki I (1999) Murine models of depression. Psychopharmacology (Berl) 147:14–16.CrossRefGoogle Scholar
  15. de Paulis T (2007) Drug evaluation: Vilazodone--a combined SSRI and 5-HT1A partial agonist for the treatment of depression. IDrugs 10:193–201.PubMedGoogle Scholar
  16. de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl) 75:134–143.CrossRefGoogle Scholar
  17. Dierich A, Kieffer BL (2004) Knockout mouse models in pain research. Methods Mol Med 99:269–299.PubMedGoogle Scholar
  18. Drews E, Schneider M, Koch M (2005) Effects of the cannabinoid receptor agonist win 55,212–2 on operant behavior and locomotor activity in rats. Pharmacol Biochem Behav 80:145–150.PubMedCrossRefGoogle Scholar
  19. Eberle MA, Ng PC, Kuhn K, Zhou L, Peiffer DA, Galver L, Viaud-Martinez KA, Lawley CT, Gunderson KL, Shen R, Murray SS (2007) Power to detect risk alleles using genome-wide tag SNP panels. PLoS Genet 3:1827–1837.PubMedCrossRefGoogle Scholar
  20. Fan JB, Chee MS, Gunderson KL (2006) Highly Parallel genomic assays. Nat Rev Genet 7:632–644.PubMedCrossRefGoogle Scholar
  21. Flint J (2003) Analysis of quantitative trait loci that influence animal behavior. J Neurobiol 54:46–77.PubMedCrossRefGoogle Scholar
  22. France CP, Woods JH (1989) Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys. J Pharmacol Exp Ther 250:937–943.PubMedGoogle Scholar
  23. Gaveriaux-Ruff C, Kieffer BL (2007) Conditional gene targeting in the mouse nervous system: Insights into brain function and diseases. Pharmacol Ther 113:619–634.PubMedCrossRefGoogle Scholar
  24. Gellert VF, Sparber SB (1977) A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats. J Pharmacol Exp Ther 201:44–54.PubMedGoogle Scholar
  25. Hansson AC, Bermudez-Silva FJ, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R, Rodriguez de Fonseca F, Kunos G, Sommer WH, Heilig M (2007) Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32:117–126.PubMedCrossRefGoogle Scholar
  26. Jarosik J, Legutko B, Unsicker K, von Bohlen und Halbach O (2007) Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy. Exp Neurol 204:20–28.PubMedCrossRefGoogle Scholar
  27. Jentsch JD, Henry PJ, Mason PA, Merritt JH, Ziriax JM (1998) Establishing orally self-administered cocaine as a reinforcer in rats using home-cage pre-exposure. Prog Neuropsychopharmacol Biol Psychiatr 22:229–239.CrossRefGoogle Scholar
  28. Katz RJ (1982) Animal model of depression: pharmacological sensitivity of a hedonic deficit. Pharmacol Biochem Behav 16:965–968.PubMedCrossRefGoogle Scholar
  29. Kelly JP, Wrynn AS, Leonard BE (1997) The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74:299–316.PubMedCrossRefGoogle Scholar
  30. Koob GF, Caine SB, Parsons L, Markou A, Weiss F (1997) Opponent process model and psychostimulant addiction. Pharmacol Biochem Behav 57:513–521.PubMedCrossRefGoogle Scholar
  31. Kosten TR, O’Connor PG (2003) Management of drug and alcohol withdrawal. N Engl J Med 348:1786–1795.PubMedCrossRefGoogle Scholar
  32. Lucki I, Dalvi A, Mayorga AJ (2001) Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 155:315–322.CrossRefGoogle Scholar
  33. Mayo-Smith MF (1997) Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. Jama 278:144–151.Google Scholar
  34. McArthur R, Borsini F (2006) Animal models of depression in drug discovery: a historical perspective. Pharmacol Biochem Behav 84:436–452.PubMedCrossRefGoogle Scholar
  35. Meisch RA, Lemaire GA, Cutrell EB (1992) Oral self-administration of pentobarbital by rhesus monkeys: relative reinforcing effects under concurrent signalled differential-reinforcement-of-low-rates schedules. Drug Alcohol Depend 30:215–225.PubMedCrossRefGoogle Scholar
  36. Meyer-Lindenberg A, Weinberger DR (2006) Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818–827.PubMedCrossRefGoogle Scholar
  37. Murray CJL, Lopez AD (1996) Evidence-based health policy – Lessons from the global burden of disease study. Science 274:740–743.PubMedCrossRefGoogle Scholar
  38. Nelson JC, Charney DS (1981) The symptoms of major depressive illness. Am J Psychiatr 138:1–13.PubMedCrossRefGoogle Scholar
  39. Otmakhova NA, Gurevich EV, Katkov YA, Nesterova IV, Bobkova NV (1992) Dissociation of multiple behavioral effects between olfactory bulbectomized C57Bl/6J and DBA/2J mice. Physiol Behav 52:441–448.PubMedCrossRefGoogle Scholar
  40. Overmier JB, Seligman ME (1967) Effects of inescapable shock upon subsequent escape and avoidance responding. J Comp Physiol Psychol 63:28–33.PubMedCrossRefGoogle Scholar
  41. Palomo T, Archer T, Kostrzewa RM, Beninger RJ (2007) Comorbidity of substance abuse with other psychiatric disorders. Neurotox Res 12:17–27.PubMedCrossRefGoogle Scholar
  42. Papp M, Moryl E, Willner P (1996) Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol 296:129–136.PubMedCrossRefGoogle Scholar
  43. Paterson NE, Markou A (2007) Animal models and treatments for addiction and depression co-morbidity. Neurotox Res 11:1–32.PubMedCrossRefGoogle Scholar
  44. Pfeifer A (2006) Lentiviral transgenesis – a versatile tool for basic research and gene therapy. Curr Gene Ther 6:535–542.PubMedCrossRefGoogle Scholar
  45. PhillipsTJ (1997) Behavior genetics of drug sensitization. Crit Rev Neurobiol 11:21–33. PubMedGoogle Scholar
  46. Pinkston JW, Branch MN (2003) Sensitization to cocaine in pigeons: interaction with an operant contingency. Exp Clin Psychopharmacol 11:102–109.PubMedCrossRefGoogle Scholar
  47. Porsolt RD, Bertin A, Jalfre M (1977a) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336.Google Scholar
  48. Porsolt RD, Le Pichon M, Jalfre M (1977b) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730–732.CrossRefGoogle Scholar
  49. Ristevski S (2005) Making better transgenic models: conditional, temporal, and spatial approaches. Mol Biotechnol 29:153–163.PubMedCrossRefGoogle Scholar
  50. Robbins PR (1974) Depression and drug addiction. Psychiatr Q 48:374–386.PubMedCrossRefGoogle Scholar
  51. Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396:157–198.PubMedCrossRefGoogle Scholar
  52. Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 Suppl. 2:S91–S117.Google Scholar
  53. Ropers HH (2007) New perspectives for the elucidation of genetic disorders. Am J Hum Genet 81:199–207.PubMedCrossRefGoogle Scholar
  54. Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R, Heath MJ (2001) Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98:1912–1917.PubMedCrossRefGoogle Scholar
  55. Sarter M, Bruno J (2002) Animal models in biological psychiatry. In: D’Haenen H, Den Boer H, Willner P, eds. Textbook of Biological Psychiatry Wiley.Chichester:Google Scholar
  56. Scattoni ML, McFarlane HG, Zhodzishsky V, Caldwell HK, Young WS, Ricceri L, Crawley JN (2007) Reduced ultrasonic vocalizations in vasopressin 1b knockout mice. Behav Brain Res.Google Scholar
  57. Schmidt-Supprian M, Rajewsky K (2007) Vagaries of conditional gene targeting. Nat Immunol 8:665–668.PubMedCrossRefGoogle Scholar
  58. Schulteis G, Markou A, Cole M, Koob GF (1995) Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 92:5880–5884.PubMedCrossRefGoogle Scholar
  59. Self DW, Nestler EJ (1995) Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463–495.PubMedCrossRefGoogle Scholar
  60. Seligman ME, Beagley G (1975) Learned helplessness in the rat. J Comp Physiol Psychol 88:534–541.PubMedCrossRefGoogle Scholar
  61. Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7:118–130.PubMedCrossRefGoogle Scholar
  62. Sieberts SK, Schadt EE (2007) Moving toward a system genetics view of disease. Mamm Genome 18:389–401.PubMedCrossRefGoogle Scholar
  63. Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627–647.PubMedCrossRefGoogle Scholar
  64. Steru L, Chermat R, Thierry B, Mico JA, Lenegre A, Steru M, Simon P, Porsolt RD (1987) The automated Tail Suspension Test: a computerized device which differentiates psychotropic drugs. Prog Neuropsychopharmacol Biol Psychiatr 11:659–671.CrossRefGoogle Scholar
  65. Stewart BS, Lemaire GA, Roache JD, Meisch RA (1994) Establishing benzodiazepines as oral reinforcers: midazolam and diazepam self-administration in rhesus monkeys. J Pharmacol Exp Ther 271:200–211.PubMedGoogle Scholar
  66. Stinus L, Caille S, Koob GF (2000) Opiate withdrawal-induced place aversion lasts for up to 16 weeks. Psychopharmacology (Berl) 149:115–120.CrossRefGoogle Scholar
  67. Takao K, Yamasaki N, Miyakawa T (2007) Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders. Neurosci Res 58:124–132.PubMedCrossRefGoogle Scholar
  68. Tsankova N, Renthal W, Kumar A, Nestler EJ (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8:355–367.PubMedCrossRefGoogle Scholar
  69. Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) Paradigm: update of the last decade. Addict Biol 12:227–462.PubMedCrossRefGoogle Scholar
  70. Wahlsten D, Rustay NR, Metten P, Crabbe JC (2003) In search of a better mouse test. Trends Neurosci 26:132–136.PubMedCrossRefGoogle Scholar
  71. Watson WP, Little HJ (1999) Correlation between increases in dihydropyridine binding in vivo and behavioural signs of ethanol withdrawal in mice. Alcohol Alcohol 34:35–42.PubMedGoogle Scholar
  72. Watson WP, Misra A, Cross AJ, Green AR, Little HJ (1994) The differential effects of felodipine and nitrendipine on cerebral dihydropyridine binding ex vivo and the ethanol withdrawal syndrome in mice. Br J Pharmacol 112:1017–1024.PubMedGoogle Scholar
  73. Willner P (1995) Animal-models of depression – validity and applications. Depression and Mania 49:19–41.Google Scholar
  74. Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90–110.PubMedCrossRefGoogle Scholar
  75. Willner P, Mitchell PJ (2002) The validity of animal models of predisposition to depression. Behav Pharmacol 13:169–188.PubMedCrossRefGoogle Scholar
  76. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93:358–364.CrossRefGoogle Scholar
  77. Winslow JT, Hearn EF, Ferguson J, Young LJ, Matzuk MM, Insel TR (2000) Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse. Horm Behav 37:145–155.PubMedCrossRefGoogle Scholar
  78. Wolgin DL, Hertz JM (1995) Effects of acute and chronic cocaine on milk intake, body weight, and activity in bottle- and cannula-fed rats. Behav Pharmacol 6:746–753.PubMedGoogle Scholar
  79. Wurbel H (2002) Behavioral phenotyping enhanced--beyond (environmental) standardization. Genes Brain Behav 1:3–8.PubMedCrossRefGoogle Scholar
  80. Zhang F, Aravanis AM, Adamantidis A, de Lecea L, Deisseroth K (2007) Circuit-breakers: optical technologies for probing neural signals and systems. Nat Rev Neurosci 8:577–581.PubMedCrossRefGoogle Scholar
  81. Zueger M, Urani A, Chourbaji S, Zacher C, Roche M, Harkin A, Gass P (2005) Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci Lett 374:142–146.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Eva Drews
  • Astrid Becker
  • Andras Bilkei-Gorzo
  • Andreas Zimmer
    • 1
  1. 1.Institute of Molecular PsychiatryLife & Brain CenterBonnGermany

Personalised recommendations